Hims and Hers gains on forecast raise, higher quarterly revenue
BUZZ-Hims and Hers gains on forecast raise, higher quarterly revenue ** Shares of telehealth firm Hims & Hers HIMS.N up 3% at $33 in extended trading
** HIMS posts rise in Q2 revenue and raises annual forecast, helped by an increase in subscribers and expanded personalized healthcare offerings
** Reports Q2 revenue of $753 million, compared with $544 million a year ago; analysts had estimated revenue of $699.89 million, according to LSEG-compiled data
** Raises FY26 revenue forecast to a range of $3.1 billion to $3.3 billion from its previous range of 2.8 billion to $3 billion
** Including session's moves, shares down 2.2% YTD
(Reporting by Katha Kalia in Bengaluru)
Recent news on Hims & Hers Health
See all newsBrief: Hims & Hers Health Expands Testosterone Care With Injectable And Oral TRT
Hims & Hers Health launches online weight management service for men in Germany
Corrected: US FDA takes step to change peptide compounding policy (Oct 15)
Brief: Hims & Hers Names Jon Franklin As Chief Accounting Officer
Brief: Hims & Hers Names Chief Medical Officers In The Uk And Australia, Deepening Its Investment In Local Clinical Leadership